CDCA8 was reported to stimulate tumor development of hepatocellular carcinoma (HCC) via the potentiation of cell cycle progression factors, such as cyclins, Ki 67, and PCNA [30,31]. The gene discussed is PCNA; the disease is hepatocellular carcinoma.